Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma

Clinical trial NCT02584829 · TERMINATED

Trial details

NCT number

NCT02584829

Sponsor

Fred Hutchinson Cancer Center

Status

TERMINATED

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2015-11-06

Primary completion

2018-12-18

Enrollment

8

View on ClinicalTrials.gov